264 related articles for article (PubMed ID: 16337594)
1. MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein.
Sdek P; Ying H; Chang DL; Qiu W; Zheng H; Touitou R; Allday MJ; Xiao ZX
Mol Cell; 2005 Dec; 20(5):699-708. PubMed ID: 16337594
[TBL] [Abstract][Full Text] [Related]
2. Targeting retinoblastoma protein for degradation by proteasomes.
Ying H; Xiao ZX
Cell Cycle; 2006 Mar; 5(5):506-8. PubMed ID: 16552188
[TBL] [Abstract][Full Text] [Related]
3. Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells.
Qiu W; Wu J; Walsh EM; Zhang Y; Chen CY; Fujita J; Xiao ZX
Oncogene; 2008 Jul; 27(29):4034-43. PubMed ID: 18332869
[TBL] [Abstract][Full Text] [Related]
4. MDMX exerts its oncogenic activity via suppression of retinoblastoma protein.
Zhang H; Hu L; Qiu W; Deng T; Zhang Y; Bergholz J; Xiao ZX
Oncogene; 2015 Oct; 34(44):5560-9. PubMed ID: 25703327
[TBL] [Abstract][Full Text] [Related]
5. The central acidic domain of MDM2 is critical in inhibition of retinoblastoma-mediated suppression of E2F and cell growth.
Sdek P; Ying H; Zheng H; Margulis A; Tang X; Tian K; Xiao ZX
J Biol Chem; 2004 Dec; 279(51):53317-22. PubMed ID: 15485814
[TBL] [Abstract][Full Text] [Related]
6. ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2.
Chang DL; Qiu W; Ying H; Zhang Y; Chen CY; Xiao ZX
Oncogene; 2007 Jul; 26(32):4627-34. PubMed ID: 17297463
[TBL] [Abstract][Full Text] [Related]
7. Effects of MdmX on Mdm2-mediated downregulation of pRB.
Uchida C; Miwa S; Isobe T; Kitagawa K; Hattori T; Oda T; Yasuda H; Kitagawa M
FEBS Lett; 2006 Mar; 580(7):1753-8. PubMed ID: 16510145
[TBL] [Abstract][Full Text] [Related]
8. MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation.
Jin Y; Lee H; Zeng SX; Dai MS; Lu H
EMBO J; 2003 Dec; 22(23):6365-77. PubMed ID: 14633995
[TBL] [Abstract][Full Text] [Related]
9. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway.
Boyer SN; Wazer DE; Band V
Cancer Res; 1996 Oct; 56(20):4620-4. PubMed ID: 8840974
[TBL] [Abstract][Full Text] [Related]
10. A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway.
Brignone C; Bradley KE; Kisselev AF; Grossman SR
Oncogene; 2004 May; 23(23):4121-9. PubMed ID: 15064742
[TBL] [Abstract][Full Text] [Related]
11. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.
Wang J; Sampath A; Raychaudhuri P; Bagchi S
Oncogene; 2001 Aug; 20(34):4740-9. PubMed ID: 11498796
[TBL] [Abstract][Full Text] [Related]
12. NRF3-POMP-20S Proteasome Assembly Axis Promotes Cancer Development via Ubiquitin-Independent Proteolysis of p53 and Retinoblastoma Protein.
Waku T; Nakamura N; Koji M; Watanabe H; Katoh H; Tatsumi C; Tamura N; Hatanaka A; Hirose S; Katayama H; Tani M; Kubo Y; Hamazaki J; Hamakubo T; Watanabe A; Murata S; Kobayashi A
Mol Cell Biol; 2020 Apr; 40(10):. PubMed ID: 32123008
[TBL] [Abstract][Full Text] [Related]
13. The levels of MDM2 protein are decreased by a proteasome-mediated proteolysis prior to caspase-3-dependent pRb and PARP cleavages.
Cho JW; Park JC; Lee JC; Kwon TK; Park JW; Baek WK; Suh SI; Suh MH
J Korean Med Sci; 2001 Apr; 16(2):135-9. PubMed ID: 11306736
[TBL] [Abstract][Full Text] [Related]
14. HAUSP, a novel deubiquitinase for Rb - MDM2 the critical regulator.
Bhattacharya S; Ghosh MK
FEBS J; 2014 Jul; 281(13):3061-78. PubMed ID: 24823443
[TBL] [Abstract][Full Text] [Related]
15. Modulation of p53 degradation via MDM2-mediated ubiquitylation and the ubiquitin-proteasome system during reperfusion after stroke: role of oxidative stress.
Saito A; Hayashi T; Okuno S; Nishi T; Chan PH
J Cereb Blood Flow Metab; 2005 Feb; 25(2):267-80. PubMed ID: 15678128
[TBL] [Abstract][Full Text] [Related]
16. Gankyrin: an intriguing name for a novel regulator of p53 and RB.
Lozano G; Zambetti GP
Cancer Cell; 2005 Jul; 8(1):3-4. PubMed ID: 16023592
[TBL] [Abstract][Full Text] [Related]
17. Evidence that proteasome-dependent degradation of the retinoblastoma protein in cells lacking A-type lamins occurs independently of gankyrin and MDM2.
Nitta RT; Smith CL; Kennedy BK
PLoS One; 2007 Sep; 2(9):e963. PubMed ID: 17896003
[TBL] [Abstract][Full Text] [Related]
18. Destabilization of Rb by human papillomavirus E7 is cell cycle dependent: E2-25K is involved in the proteolysis.
Oh KJ; Kalinina A; Bagchi S
Virology; 2010 Jan; 396(1):118-24. PubMed ID: 19906396
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation.
Uchida C; Miwa S; Kitagawa K; Hattori T; Isobe T; Otani S; Oda T; Sugimura H; Kamijo T; Ookawa K; Yasuda H; Kitagawa M
EMBO J; 2005 Jan; 24(1):160-9. PubMed ID: 15577944
[TBL] [Abstract][Full Text] [Related]
20. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53.
Higashitsuji H; Higashitsuji H; Itoh K; Sakurai T; Nagao T; Sumitomo Y; Masuda T; Dawson S; Shimada Y; Mayer RJ; Fujita J
Cancer Cell; 2005 Jul; 8(1):75-87. PubMed ID: 16023600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
